Predictors of hematoma volume in deep and lobar supratentorial intracerebral hemorrhage

JAMA Neurology

Volumn 70, Issue 8, 2013, Pages 988-994

  Falcone, Guido J ^a,b   Biffi, Alessandro ^a   Brouwers, H Bart ^a   Anderson, Christopher D ^a   Battey, Thomas W K ^a   Ayres, Alison M ^a   Vashkevich, Anastasia ^a   Schwab, Kristin ^a   Rost, Natalia S ^a   Goldstein, Joshua N ^a   Viswanathan, Anand ^a   Greenberg, Steven M ^a   Rosand, Jonathan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; BRAIN RADIOGRAPHY; BRAIN REGION; CAUSE OF DEATH; CLINICAL EVALUATION; COHORT ANALYSIS; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; INTERNATIONAL NORMALIZED RATIO; INTRACEREBRAL HEMORRHAGE VOLUME; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NERVOUS SYSTEM PARAMETERS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 84882341352     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.98     Document Type: Article

References (21)

1. Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012;11(8):720-731.
2. Biffi A, Anderson CD, Jagiella JM, et al International Stroke Genetics Consortium. APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study. Lancet Neurol. 2011;10(8): 702-709.
3. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24(7):987-993.
4. Broderick JP, Diringer MN, Hill MD, et al Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke. 2007;38(3):1072-1075.
5. Mayer SA, Brun NC, Begtrup K, et al Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352(8):777-785.
6. Mayer SA, Brun NC, Begtrup K, et al FAST Trial Investigators. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358(20): 2127-2137.
7. Anderson CS, Huang Y,Wang JG, et al INTERACT Investigators. Intensive Blood Pressure Reduction In Acute Cerebral Haemorrhage Trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7(5):391-399.
8. Anderson CS, Huang Y, Arima H, et al INTERACT Investigators. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT). Stroke. 2010;41(2):307-312.
9. Flaherty ML, Tao H, Haverbusch M, et al. Warfarin use leads to larger intracerebral hematomas. Neurology. 2008;71(14):1084-1089.
10. Ricard G, Garant M-P, Carrier N, Leblanc N, Boulanger J-M. Statinsmay increase intracerebral hemorrhage volume. Can J Neurol Sci. 2010;37(6): 791-796.
11. Lou M, Al-Hazzani A, Goddeau RP Jr, Novak V, Selim M. Relationship between white-matter hyperintensities and hematoma volume and growth in patients with intracerebral hemorrhage. Stroke. 2010;41(1):34-40.
12. Lee S-H, Kim BJ, Roh J-K. Silent microbleeds are associated with volume of primary intracerebral hemorrhage. Neurology. 2006;66(3):430-432.
13. Biffi A, Sonni A, Anderson CD, et al International Stroke Genetics Consortium. Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol. 2010;68(6): 934-943.
14. Wojcik NC, HuebnerWW, Jorgensen G. Strategies for using the National Death Index and the Social Security Administration for death ascertainment in large occupational cohort mortality studies. Am J Epidemiol. 2010;172(4): 469-477.
15. Goldstein JN, Fazen LE, Snider R, et al. Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology. 2007;68(12):889-894.
16. Flibotte JJ, Hagan N, O'Donnell J, Greenberg SM, Rosand J.Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology. 2004;63(6):1059-1064.
17. Zidan AH, Girvin JP. Effect on the Cushing response of different rates of expansion of a supratentorial mass. J Neurosurg. 1978;49(1):61-70.
18. Price JF, Fowkes FG. Risk factors and the sex differential in coronary artery disease. Epidemiology. 1997;8(5):584-591.
19. WasayM, Yousuf A, Lal D, Awan S. Predictors of the intracerebral hemorrhage volume in hypertensive patients. Cerebrovasc Dis Extra. 2011;1(1):1-5.
20. Biffi A, Halpin A, Towfighi A, et al. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology. 2010;75(8): 693-698.
21. Brouwers HB, Falcone GJ, McNamara KA, et al. CTA spot sign predicts hematoma expansion in patients with delayed presentation after intracerebral hemorrhage. Neurocrit Care. 2012;17(3):421-428.